Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 78490701 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Domestic Representative | Wm. Charles Saunders |
Attorney Name | Wm. Charles Saunders |
Law Office Assigned | M20 |
Employee Name | BELLO, ZACHARY R |
2004-09-28 | Application Filed |
2007-08-07 | Abandon |
2007-09-05 | Location: TMO LAW OFFICE 111 - DOCKET CLERK |
2007-09-05 | Status: Dead/Abandoned |
2018-07-08 | Transaction Date |
Owner: | ![]() |
Address | 15 Stanhope Gate London GB W1K 1LN |
Legal Entity Type | Limited Liability Company |
Legal Entity State | GB |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
International Codes: | 16 |
U.S. Codes: | 002,005,022,023,029,037,038,050 |
International Codes: | 35 |
U.S. Codes: | 100,101,102 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system; pharmaceutical preparations and substances for use in pain control, arthritis, anaesthesia, oncology, infection, inflammation, urology, gynaecology; pharmaceutical preparations and substances for the treatment and prevention of diabetes |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2004-10-04 | 1 NWAP I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2005-04-22 | 2 DOCK D:Assigned to Examiner |
PRIORITY ACTION WRITTEN | 2005-04-28 | 3 CPRA R:Renewal |
PRIORITY ACTION MAILED | 2005-04-29 | 4 CPRA F:First Action |
PAPER RECEIVED | 2005-06-09 | 5 MAIL I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2005-06-09 | 6 CRFA I:Incoming Correspondence |
AMENDMENT FROM APPLICANT ENTERED | 2005-06-16 | 7 ACEC I:Incoming Correspondence |
SUSPENSION LETTER WRITTEN | 2005-06-27 | 8 CNSL R:Renewal |
LETTER OF SUSPENSION MAILED | 2005-06-28 | 9 CNSL S: |
SUSPENSION INQUIRY WRITTEN | 2006-01-11 | 10 CNSI R:Renewal |
INQUIRY AS TO SUSPENSION MAILED | 2006-01-11 | 11 CNSI S: |
PAPER RECEIVED | 2006-07-10 | 12 MAIL I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2006-07-10 | 13 CRFA I:Incoming Correspondence |
AMENDMENT FROM APPLICANT ENTERED | 2006-08-01 | 14 ACEC I:Incoming Correspondence |
SUSPENSION LETTER WRITTEN | 2006-08-02 | 15 CNSL R:Renewal |
LETTER OF SUSPENSION MAILED | 2006-08-02 | 16 CNSL S: |
SUSPENSION INQUIRY WRITTEN | 2007-02-06 | 17 CNSI R:Renewal |
INQUIRY AS TO SUSPENSION MAILED | 2007-02-07 | 18 CNSI S: |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2007-07-30 | 19 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2007-07-30 | 20 ARAA I:Incoming Correspondence |
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2007-09-05 | 21 ABN2 O:Outgoing Correspondence |
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2007-09-06 | 22 MAB2 O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.